http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-5011116-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17
filingDate 1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d027192c33d7f4a36ccf46c3e21140f
publicationDate 2001-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-5011116-A1
titleOfInvention COMBINATIONS FOR SULFONILUREA-GLITAZONA DIABETES
abstract A composition comprising effective synergistic amounts of a sulfonylurea antidiabetic agent of Formula: where A is hydrogen, halo, or an organic radical such as alkyl, alkanoyl, aryl, aralkyl, heteroaryl and cycloalkyl, and B is alkyl, cycloalkyl and a heterocyclic group such as hexahydroazepine, said sulfonylurea antidiabetic agent being selected from glisoxépido, glyuburide, acetohexamide, chloropropamide, glibornuride, tolbutamide, tolazamide, glipizide, gliclazide, gliquidone, glihexamide, tolbutamide; and a glitazone antidiabetic agent of Formula: where n is 1, 2 or 3, Y and Z are independently Oó NH, and E is an aromatic or non-aromatic cyclic or bicyclic ring optionally containing a heteroatom selected from oxygen or nitrogen; preferably an antidiabetic deglitazone agent of Formula: where: R1 and R2 are independently hydrogen to C1-C5 alkyl; R3 is hydrogen, an aliphatic C1-C6 acyl group, an alicyclic acyl group, an aromatic acyl group, a heterocyclic acyl group, an araliphatic acyl group, a carbonyl group (C1-C6 alkoxy) or an aralkyloxycarbonyl group; R4 and R5 are independently hydrogen, C1-C5 alkyl, C1-C5 alkoxy; or R4 and R5 together are C1-C4 alkylenedioxy; ...
priorityDate 1998-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12818200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420791830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10198397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11819083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414671823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3475
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426328800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3478

Total number of triples: 41.